Le Lézard
Classified in: Business
Subject: ATY

Scott+Scott Attorneys at Law LLP Announces Investigation into Proteostasis Therapeutics, Inc. (PTI)


NEW YORK, March 21, 2018 /PRNewswire/ -- Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, is investigating whether Proteostasis Therapeutics, Inc. ("Proteostasis" or the "Company") (NASDAQ: PTI) or certain of its officers and directors violated federal securities or other laws.  If you are a Proteostasis stockholder, you are encouraged to contact a Scott+Scott attorney at (844) 818-6980 for more information.

Proteostasis is a biopharmaceutical company.  The investigation centers around the Company's cystic-fibrosis drug, PTI-428.

On March 20, 2018, Kerrisdale Capital Management LLC published a report entitled "Proteostasis Therapeutics, Inc.: Don't Hold Your Breath" which was also published on Seeking Alpha with the title, "Hyped-Up Lung Data? Just A Lot Of Hot Air."  The report claims that in the Phase 2 study for PTI-428, "the placebo group's small size and anomalously bad outcomes misleadingly make the treatment group's unimpressive results look good by comparison."  Accordingly, the report concluded that the drug "is ineffective and will likely fail future Phase 3 trials."  The report also asserts that "Proteostasis has a habit of sweeping unpleasant or confusing findings under the rug."

On this news, Proteostasis's share price fell 26% on March 20, 2018, and closed at $5.16 after its previous close of $6.99.

What You Can Do

If you are a Proteostasis shareholder, and you wish to discuss this investigation, please contact attorney Rhiana Swartz at (844) 818-6980, or at [email protected].

About Scott+Scott Attorneys at Law LLP

Scott+Scott has significant experience in prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States.  The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Connecticut, California, and Ohio.

Attorney Advertising

CONTACT:

Rhiana Swartz
Scott+Scott Attorneys at Law LLP
230 Park Ave, 17th Fl, NY, NY 10169
(844) 818-6980
[email protected]

SOURCE Scott+Scott Attorneys at Law LLP


These press releases may also interest you

at 01:00
M360 Eurasia, hosted by the GSMA and with Host Sponsor Azercell, will return to Baku from 15-16 May 2024 at the JW Marriott Absheron Baku Hotel. M360 Eurasia convenes executives from leading corporations in mobile and vertical sectors, as well as...

at 01:00
BlockFills, a market leader in digital asset trading technology with 24/7 digital asset liquidity provision being among the firm's boutique of consultative fintech services, announced their full integration with Centroid Bridge of Centroid Solutions....

at 00:30
Catalyst, a global nonprofit promoting gender equity and workplace inclusion, has named Kathy Warden, CEO of Northrop Grumman Corporation, Chair of its Board. She succeeds Accenture CEO Julie Sweet and is the fourth woman to chair the Board.  ...

at 00:00
Health Carousel, renowned for its dedication to enhancing the healthcare staffing sector, today unveiled its groundbreaking 'Full Circle of Support' program. This initiative represents a significant investment in the total well-being of its...

at 00:00
QuantumWork Advisory, a specialized global workforce advisory and transformation firm, has acquired Talent Tech Labs (TTL), a world-class research firm renowned for its in-depth understanding of the evolving workforce technology landscape. This...

17 avr 2024
Sungrow, the global leading PV inverter and energy storage system provider, exhibited its cutting-edge and comprehensive renewable energy solutions at the World Future Energy Summit (WFES) 2024. Notably, Sungrow has achieved a remarkable milestone by...



News published on and distributed by: